Daniel G. Welch, Director at SEATTLE GENETICS INC /WA (SGEN), sold 64,111 shares at $164.21 ($10.6M) on 2020-05-06, disclosed to the SEC on 2020-05-07.
Seasonal sale ($10.6M) by Director — this insider has traded SGEN in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.62 | 3,305 | $547K | 5.1% |
| 2 | $165.62 | 3,305 | $547K | 5.1% |
| 3 | $166.27 | 5,400 | $898K | 8.4% |
| 4 | $167.26 | 11,011 | $1.8M | 17.3% |
| 5 | $167.26 | 11,011 | $1.8M | 17.3% |
| 6 | $167.99 | 284 |
| $48K |
| 0.4% |
| 7 | $164.21 | 8,041 | $1.3M | 12.4% |
| 8 | $164.21 | 8,041 | $1.3M | 12.4% |
| 9 | $164.98 | 4,319 | $713K | 6.7% |
| 10 | $164.98 | 4,319 | $713K | 6.7% |
| 11 | $166.23 | 2,435 | $405K | 3.8% |
| 12 | $166.23 | 2,435 | $405K | 3.8% |
| 13 | $166.77 | 205 | $34K | 0.3% |
| Total | $165.86 avg | 64,111 | $10.6M | 100% |
| Filing → |
| SGEN | SELL | 2023-05-03 | $9.8M | — | Filing → |
| SGEN | SELL | 2023-04-05 | $12.5M | — | Filing → |
| SGEN | SELL | 2023-03-17 | $1.4M | — | Filing → |